Abbott’s Settlement Over Baby Formula Plant Contamination
In a significant resolution to the 2022 baby formula crisis, Abbott Laboratories has agreed to a $385 million settlement. This settlement addresses claims related to contamination issues at the company’s Sturgis, Michigan factory, which is the largest infant formula plant in the United States. These problems led to nationwide supply shortages last year.
The contamination concerns at the Sturgis plant spurred a recall of several powdered infant formulas, including the well-known Similac brand. This recall exacerbated existing supply issues that were already strained due to pandemic-related disruptions and consumer stockpiling.
Although Abbott maintains that the settlement is not an admission of guilt or liability, it also covers lawsuits from various state Attorneys General and individual relators. The company states that government tests on unopened products from affected households were negative for Cronobacter sakazakii, a bacterium harmful to infants. Furthermore, Abbott asserts that none of their unopened distributed formulas have tested positive for this bacterium.
The Justice Department, during the Trump administration, concluded its criminal investigation into the Sturgis plant’s contamination. Meanwhile, the Biden administration implemented measures to alleviate the formula shortage by easing import restrictions, organizing airlifts of formula from Europe, and invoking emergency production rules.
The Sturgis facility was temporarily shut down in February 2022 following an FDA investigation but resumed operations by June of the same year.
—
Read More Michigan News
